Related Experiment Video

Updated: May 3, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.0K

Hexavalent vaccines for immunization in paediatric age

S Esposito1, C Tagliabue, S Bosis

  • 1Paediatric High Intensity Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|January 28, 2014
PubMed

Insights

Combined hexavalent vaccines simplify immunization schedules, reducing missed vaccinations and healthcare costs. This review examines the immunogenicity, efficacy, and safety of these combination vaccines against diphtheria, tetanus, pertussis, hepatitis B, polio, and Hib.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Increasing vaccine availability can complicate immunization schedules, potentially reducing coverage.
  • Combined vaccines offer benefits like fewer patient visits, reduced injection complications, and lower costs.
  • Combined vaccines minimize the risk of delayed or missed vaccinations.

Purpose of the Study:

  • To review the immunogenicity, efficacy, safety, and tolerability of hexavalent vaccines.
  • To discuss commercially available and developing hexavalent vaccine preparations.

Main Methods:

  • Literature review of studies on hexavalent vaccines.
  • Analysis of immunogenicity, efficacy, safety, and tolerability data.
  • Comparison of available and developmental hexavalent vaccine formulations.

Main Results:

  • Hexavalent vaccines combine antigens for diphtheria, tetanus, acellular pertussis (DTaP), hepatitis B (HBsAg), poliomyelitis (P1, P2, P3), and Haemophilus influenzae type B (Hib).
  • Data on immunogenicity, efficacy, safety, and tolerability of various hexavalent vaccines are presented.
  • Both available and developmental hexavalent vaccines are assessed.

Conclusions:

  • Hexavalent vaccines present a viable strategy to improve vaccination coverage and adherence.
  • These combination vaccines demonstrate favorable immunogenicity, efficacy, and safety profiles.
  • Further development and implementation of hexavalent vaccines are supported by current evidence.

Keywords:
Anti-HBscombined vaccineshepatitis Bhexavalent vaccinepertactinpertussis

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.3K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.0K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.1K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
144